Leveraging Next-Generation Sequencing Data to Refine Immunotherapy Response Prediction in NSCLC: Programmed Death-Ligand 1 Copy Number, Tumor Mutation Burden, and Beyond.
作者信息
Inamura Kentaro
机构信息
Division of Pathology, The Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan; Department of Pathology, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
出版信息
J Thorac Oncol. 2023 Sep;18(9):e87-e88. doi: 10.1016/j.jtho.2023.05.009.
PMID:37599050
Abstract
摘要
Zotero 插件